Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis.
about
Pre-admission antibiotics for suspected cases of meningococcal diseasePre-admission antibiotics for suspected cases of meningococcal diseaseVaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysisLong term sequelae from childhood pneumonia; systematic review and meta-analysisGlobal, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013Health and economic outcomes of introducing the new MenB vaccine (Bexsero) into the Italian routine infant immunisation programmeEstimates of neonatal morbidities and disabilities at regional and global levels for 2010: introduction, methods overview, and relevant findings from the Global Burden of Disease study.Toll-like receptor 9 polymorphisms are associated with severity variables in a cohort of meningococcal meningitis survivors.Predictors of outcome in acute encephalitisEvaluation of the enhanced meningitis surveillance system, Yendi municipality, northern Ghana, 2010-2015.Characteristics and outcome of spontaneous bacterial meningitis in patients with cancer compared to patients without cancer.Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development.Lifestyle risk factors for invasive pneumococcal disease: a systematic review.Epidemiology, clinical manifestations, and outcomes of Streptococcus suis infection in humans.Standard operating procedures improve acute neurologic care in a sub-Saharan African setting.Comparative economic evaluation of Haemophilus influenzae type b vaccination in Belarus and Uzbekistan.Menveo®): a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y.Polymorphisms in Toll-like receptors 2, 4, and 9 are highly associated with hearing loss in survivors of bacterial meningitis.Meningococcal serogroup B disease in Turkey: a guess or reality?Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study.The mood-stabilizer lithium prevents hippocampal apoptosis and improves spatial memory in experimental meningitis.The formyl peptide receptor like-1 and scavenger receptor MARCO are involved in glial cell activation in bacterial meningitis.In-hospital management of children with bacterial meningitis in Italy.Significant sequelae after bacterial meningitis in Niger: a cohort study.Assessment of health benefits and cost-effectiveness of 10-valent and 13-valent pneumococcal conjugate vaccination in Kenyan children.Addition of host genetic variants in a prediction rule for post meningitis hearing loss in childhood: a model updating study.High mortality amongst adolescents and adults with bacterial meningitis in sub-Saharan Africa: an analysis of 715 cases from MalawiInhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal meningitis.Spontaneous gram-negative bacillary meningitis in adult patients: characteristics and outcome.The health, social and educational needs of children who have survived meningitis and septicaemia: the parents' perspectiveModeling the impact of the 7-valent pneumococcal conjugate vaccine in Chinese infants: an economic analysis of a compulsory vaccination.The effect of Haemophilus influenzae type B and pneumococcal conjugate vaccines on childhood meningitis mortality: a systematic reviewCritical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive diseaseComparative long-term adverse effects elicited by invasive group B and C meningococcal infections.From genes to vaccine: A breakthrough in the prevention of meningococcal group B disease.Newborn hearing screening programme in Belgium: a consensus recommendation on risk factors.Streptococcus pneumoniae and Haemophilus influenzae in paediatric meningitis patients at Goroka General Hospital, Papua New Guinea: serotype distribution and antimicrobial susceptibility in the pre-vaccine era.Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country.A population-based prospective birth cohort study of childhood neurocognitive and psychological functioning in healthy survivors of early life meningitis.Assembling GHERG: Could "academic crowd-sourcing" address gaps in global health estimates?
P2860
Q24200590-23A3511D-9675-42AC-ADC7-021F3396DD92Q24242705-CB290B33-1908-44F9-9A58-9C6875EF116CQ26779489-25E0583E-D979-4A08-A868-43F2348EF3E9Q26992047-ECE6E8EA-79AD-47A2-939B-4218AD106B79Q28083357-C9C64E0A-DFF3-4925-BF0B-D868398AF229Q28391723-19F3133B-1919-45CA-B27E-7AFACB49460DQ30392619-0BD8B37F-7848-47BB-A2F2-5EE64A67BC4CQ31061460-5B2216C5-5E43-4105-AFCD-1216A1C8E023Q33409380-51FD7177-8891-43D5-AFFB-B01D1BD76FE8Q33601046-7B105E8B-C298-4625-BC08-232CCB37E5E3Q33673004-7BD07D37-398E-4C85-A65A-88DB2E542A6DQ33743483-3EFD41F2-ED8D-4700-B701-2FC9F929DEBCQ33795662-E028EEC1-26C4-4C7F-8179-A17A7BA1089DQ33816294-D15D8DB2-1BD5-4DE0-9DAE-9371EEBFCCD0Q33885261-942800B6-2D08-409A-B633-BEC7E05F9BB3Q33947953-A885B7B0-F5F0-4C6E-B90A-6E70B327AC48Q34155231-75FFA1BC-B4A4-43FF-AAF9-759508363E07Q34290855-48FA99D7-D144-4994-A987-84148CEC0EAAQ34290937-FDA07279-48EB-47FC-83CD-3F927CE7B8B2Q34316082-CAC3DFB8-4C45-48FD-B44C-4A5AC8BB532FQ34542607-1B05F9BA-502D-44DC-9748-8959E4CB4915Q34581189-AE023825-CACB-40F7-AD94-5D332D189C16Q34587235-35378BCC-AD5B-422E-A506-C68002C2515FQ34728780-68F6CF54-ECA4-4007-8343-095D2D5AB32AQ34796940-418A81B1-F504-4AE8-BD6E-BFC6E96C5BEBQ34859867-25D37BE7-B454-4984-B8B5-E3C1A3A5418CQ34874445-8DAD9828-5753-41A6-AB9A-4F641920B57EQ34989271-8A23E4D9-09EA-4331-90F2-A76F76DF5DB6Q35002271-83F27DA3-238F-4E93-AC9D-EA3B00E1F474Q35013440-7A6C457E-9467-4063-B398-C059CD45E5D6Q35089126-92DEA435-4EDF-42B8-A4B7-001C1928DF0BQ35101170-79231864-7FEE-4113-868D-8984B987B68AQ35187182-2F3244B8-5904-423A-8F7B-20D531FF5494Q35290278-C10402C3-57C8-442E-88D5-E74968DD077BQ35453441-A8C1D209-DCDA-417A-92E9-CD31240A08E4Q35811270-A80241FD-78C0-490D-9199-EE5756ED344BQ35828587-02E55AEE-AD3B-426C-A6F3-7FE61A416198Q35887617-BECC2DEB-C9F8-450C-A607-C01ABDF6D442Q36028188-72FDBFB5-388B-4491-8360-206D2C32D405Q36120877-85760115-7E26-4CC3-B4B6-997FA0196592
P2860
Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Global and regional risk of di ...... atic review and meta-analysis.
@en
Global and regional risk of di ...... atic review and meta-analysis.
@nl
type
label
Global and regional risk of di ...... atic review and meta-analysis.
@en
Global and regional risk of di ...... atic review and meta-analysis.
@nl
prefLabel
Global and regional risk of di ...... atic review and meta-analysis.
@en
Global and regional risk of di ...... atic review and meta-analysis.
@nl
P2093
P1476
Global and regional risk of di ...... atic review and meta-analysis.
@en
P2093
Andrew Clark
Colin Sanderson
Karen Edmond
Ulla K Griffiths
Viola S Korczak
P304
P356
10.1016/S1473-3099(10)70048-7
P50
P577
2010-05-01T00:00:00Z